The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Production (Research-use) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Adeno-associated virus (AAV)
1.2.3 Lentivirus
1.2.4 Adenovirus
1.2.5 Retrovirus
1.2.6 Others
1.3 Market by Application
1.3.1 Global Viral Vector Production (Research-use) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cell & Gene Therapy Development
1.3.3 Vaccine Development
1.3.4 Biopharmaceutical and Pharmaceutical Discovery
1.3.5 Biomedical Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Production (Research-use) Market Perspective (2019-2030)
2.2 Viral Vector Production (Research-use) Growth Trends by Region
2.2.1 Global Viral Vector Production (Research-use) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vector Production (Research-use) Historic Market Size by Region (2019-2024)
2.2.3 Viral Vector Production (Research-use) Forecasted Market Size by Region (2025-2030)
2.3 Viral Vector Production (Research-use) Market Dynamics
2.3.1 Viral Vector Production (Research-use) Industry Trends
2.3.2 Viral Vector Production (Research-use) Market Drivers
2.3.3 Viral Vector Production (Research-use) Market Challenges
2.3.4 Viral Vector Production (Research-use) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Production (Research-use) Players by Revenue
3.1.1 Global Top Viral Vector Production (Research-use) Players by Revenue (2019-2024)
3.1.2 Global Viral Vector Production (Research-use) Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vector Production (Research-use) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vector Production (Research-use) Revenue
3.4 Global Viral Vector Production (Research-use) Market Concentration Ratio
3.4.1 Global Viral Vector Production (Research-use) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Production (Research-use) Revenue in 2023
3.5 Viral Vector Production (Research-use) Key Players Head office and Area Served
3.6 Key Players Viral Vector Production (Research-use) Product Solution and Service
3.7 Date of Enter into Viral Vector Production (Research-use) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Production (Research-use) Breakdown Data by Type
4.1 Global Viral Vector Production (Research-use) Historic Market Size by Type (2019-2024)
4.2 Global Viral Vector Production (Research-use) Forecasted Market Size by Type (2025-2030)
5 Viral Vector Production (Research-use) Breakdown Data by Application
5.1 Global Viral Vector Production (Research-use) Historic Market Size by Application (2019-2024)
5.2 Global Viral Vector Production (Research-use) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vector Production (Research-use) Market Size (2019-2030)
6.2 North America Viral Vector Production (Research-use) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vector Production (Research-use) Market Size by Country (2019-2024)
6.4 North America Viral Vector Production (Research-use) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Production (Research-use) Market Size (2019-2030)
7.2 Europe Viral Vector Production (Research-use) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vector Production (Research-use) Market Size by Country (2019-2024)
7.4 Europe Viral Vector Production (Research-use) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Production (Research-use) Market Size (2019-2030)
8.2 Asia-Pacific Viral Vector Production (Research-use) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vector Production (Research-use) Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vector Production (Research-use) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Production (Research-use) Market Size (2019-2030)
9.2 Latin America Viral Vector Production (Research-use) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vector Production (Research-use) Market Size by Country (2019-2024)
9.4 Latin America Viral Vector Production (Research-use) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Production (Research-use) Market Size (2019-2030)
10.2 Middle East & Africa Viral Vector Production (Research-use) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vector Production (Research-use) Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vector Production (Research-use) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Detail
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Viral Vector Production (Research-use) Introduction
11.1.4 Merck KGaA Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.1.5 Merck KGaA Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Viral Vector Production (Research-use) Introduction
11.2.4 Lonza Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Detail
11.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
11.4 Cobra Biologics Ltd.
11.4.1 Cobra Biologics Ltd. Company Detail
11.4.2 Cobra Biologics Ltd. Business Overview
11.4.3 Cobra Biologics Ltd. Viral Vector Production (Research-use) Introduction
11.4.4 Cobra Biologics Ltd. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.4.5 Cobra Biologics Ltd. Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Viral Vector Production (Research-use) Introduction
11.5.4 Thermo Fisher Scientific Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Waisman Biomanufacturing
11.6.1 Waisman Biomanufacturing Company Detail
11.6.2 Waisman Biomanufacturing Business Overview
11.6.3 Waisman Biomanufacturing Viral Vector Production (Research-use) Introduction
11.6.4 Waisman Biomanufacturing Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.6.5 Waisman Biomanufacturing Recent Development
11.7 Genezen
11.7.1 Genezen Company Detail
11.7.2 Genezen Business Overview
11.7.3 Genezen Viral Vector Production (Research-use) Introduction
11.7.4 Genezen Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.7.5 Genezen Recent Development
11.8 YPOSKESI
11.8.1 YPOSKESI Company Detail
11.8.2 YPOSKESI Business Overview
11.8.3 YPOSKESI Viral Vector Production (Research-use) Introduction
11.8.4 YPOSKESI Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.8.5 YPOSKESI Recent Development
11.9 Advanced BioScience Laboratories, Inc. (ABL, Inc.)
11.9.1 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Company Detail
11.9.2 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
11.9.3 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Introduction
11.9.4 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.9.5 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Development
11.10 Novasep Holding S.A.S
11.10.1 Novasep Holding S.A.S Company Detail
11.10.2 Novasep Holding S.A.S Business Overview
11.10.3 Novasep Holding S.A.S Viral Vector Production (Research-use) Introduction
11.10.4 Novasep Holding S.A.S Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.10.5 Novasep Holding S.A.S Recent Development
11.11 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
11.11.1 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Company Detail
11.11.2 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
11.11.3 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Introduction
11.11.4 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.11.5 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Development
11.12 Vigene Biosciences, Inc.
11.12.1 Vigene Biosciences, Inc. Company Detail
11.12.2 Vigene Biosciences, Inc. Business Overview
11.12.3 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Introduction
11.12.4 Vigene Biosciences, Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.12.5 Vigene Biosciences, Inc. Recent Development
11.13 General Electric Company (GE Healthcare)
11.13.1 General Electric Company (GE Healthcare) Company Detail
11.13.2 General Electric Company (GE Healthcare) Business Overview
11.13.3 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Introduction
11.13.4 General Electric Company (GE Healthcare) Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.13.5 General Electric Company (GE Healthcare) Recent Development
11.14 CEVEC Pharmaceuticals GmbH
11.14.1 CEVEC Pharmaceuticals GmbH Company Detail
11.14.2 CEVEC Pharmaceuticals GmbH Business Overview
11.14.3 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Introduction
11.14.4 CEVEC Pharmaceuticals GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.14.5 CEVEC Pharmaceuticals GmbH Recent Development
11.15 Batavia Biosciences B.V.
11.15.1 Batavia Biosciences B.V. Company Detail
11.15.2 Batavia Biosciences B.V. Business Overview
11.15.3 Batavia Biosciences B.V. Viral Vector Production (Research-use) Introduction
11.15.4 Batavia Biosciences B.V. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.15.5 Batavia Biosciences B.V. Recent Development
11.16 Biovion oy
11.16.1 Biovion oy Company Detail
11.16.2 Biovion oy Business Overview
11.16.3 Biovion oy Viral Vector Production (Research-use) Introduction
11.16.4 Biovion oy Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.16.5 Biovion oy Recent Development
11.17 Wuxi AppTec Co., Ltd.
11.17.1 Wuxi AppTec Co., Ltd. Company Detail
11.17.2 Wuxi AppTec Co., Ltd. Business Overview
11.17.3 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Introduction
11.17.4 Wuxi AppTec Co., Ltd. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.17.5 Wuxi AppTec Co., Ltd. Recent Development
11.18 VGXI, Inc.
11.18.1 VGXI, Inc. Company Detail
11.18.2 VGXI, Inc. Business Overview
11.18.3 VGXI, Inc. Viral Vector Production (Research-use) Introduction
11.18.4 VGXI, Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.18.5 VGXI, Inc. Recent Development
11.19 Catalent Inc.
11.19.1 Catalent Inc. Company Detail
11.19.2 Catalent Inc. Business Overview
11.19.3 Catalent Inc. Viral Vector Production (Research-use) Introduction
11.19.4 Catalent Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.19.5 Catalent Inc. Recent Development
11.20 Miltenyi Biotec GmbH
11.20.1 Miltenyi Biotec GmbH Company Detail
11.20.2 Miltenyi Biotec GmbH Business Overview
11.20.3 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Introduction
11.20.4 Miltenyi Biotec GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.20.5 Miltenyi Biotec GmbH Recent Development
11.21 SIRION Biotech GmbH
11.21.1 SIRION Biotech GmbH Company Detail
11.21.2 SIRION Biotech GmbH Business Overview
11.21.3 SIRION Biotech GmbH Viral Vector Production (Research-use) Introduction
11.21.4 SIRION Biotech GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.21.5 SIRION Biotech GmbH Recent Development
11.22 Virovek Incorporation
11.22.1 Virovek Incorporation Company Detail
11.22.2 Virovek Incorporation Business Overview
11.22.3 Virovek Incorporation Viral Vector Production (Research-use) Introduction
11.22.4 Virovek Incorporation Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.22.5 Virovek Incorporation Recent Development
11.23 BioNTech IMFS GmbH
11.23.1 BioNTech IMFS GmbH Company Detail
11.23.2 BioNTech IMFS GmbH Business Overview
11.23.3 BioNTech IMFS GmbH Viral Vector Production (Research-use) Introduction
11.23.4 BioNTech IMFS GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.23.5 BioNTech IMFS GmbH Recent Development
11.24 VIVEbiotech S.L.
11.24.1 VIVEbiotech S.L. Company Detail
11.24.2 VIVEbiotech S.L. Business Overview
11.24.3 VIVEbiotech S.L. Viral Vector Production (Research-use) Introduction
11.24.4 VIVEbiotech S.L. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.24.5 VIVEbiotech S.L. Recent Development
11.25 Creative Biogene
11.25.1 Creative Biogene Company Detail
11.25.2 Creative Biogene Business Overview
11.25.3 Creative Biogene Viral Vector Production (Research-use) Introduction
11.25.4 Creative Biogene Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.25.5 Creative Biogene Recent Development
11.26 Vibalogics GmbH
11.26.1 Vibalogics GmbH Company Detail
11.26.2 Vibalogics GmbH Business Overview
11.26.3 Vibalogics GmbH Viral Vector Production (Research-use) Introduction
11.26.4 Vibalogics GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.26.5 Vibalogics GmbH Recent Development
11.27 Takara Bio.
11.27.1 Takara Bio. Company Detail
11.27.2 Takara Bio. Business Overview
11.27.3 Takara Bio. Viral Vector Production (Research-use) Introduction
11.27.4 Takara Bio. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.27.5 Takara Bio. Recent Development
11.28 Cell and Gene Therapy Catapult
11.28.1 Cell and Gene Therapy Catapult Company Detail
11.28.2 Cell and Gene Therapy Catapult Business Overview
11.28.3 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Introduction
11.28.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.28.5 Cell and Gene Therapy Catapult Recent Development
11.29 BlueBird Bio
11.29.1 BlueBird Bio Company Detail
11.29.2 BlueBird Bio Business Overview
11.29.3 BlueBird Bio Viral Vector Production (Research-use) Introduction
11.29.4 BlueBird Bio Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.29.5 BlueBird Bio Recent Development
11.30 Addgene, Inc.
11.30.1 Addgene, Inc. Company Detail
11.30.2 Addgene, Inc. Business Overview
11.30.3 Addgene, Inc. Viral Vector Production (Research-use) Introduction
11.30.4 Addgene, Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.30.5 Addgene, Inc. Recent Development
11.31 Aldevron, L.L.C.
11.31.1 Aldevron, L.L.C. Company Detail
11.31.2 Aldevron, L.L.C. Business Overview
11.31.3 Aldevron, L.L.C. Viral Vector Production (Research-use) Introduction
11.31.4 Aldevron, L.L.C. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.31.5 Aldevron, L.L.C. Recent Development
11.32 Audentes Therapeutics
11.32.1 Audentes Therapeutics Company Detail
11.32.2 Audentes Therapeutics Business Overview
11.32.3 Audentes Therapeutics Viral Vector Production (Research-use) Introduction
11.32.4 Audentes Therapeutics Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.32.5 Audentes Therapeutics Recent Development
11.33 BioMarin Pharmaceutical
11.33.1 BioMarin Pharmaceutical Company Detail
11.33.2 BioMarin Pharmaceutical Business Overview
11.33.3 BioMarin Pharmaceutical Viral Vector Production (Research-use) Introduction
11.33.4 BioMarin Pharmaceutical Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.33.5 BioMarin Pharmaceutical Recent Development
11.34 RegenxBio, Inc.
11.34.1 RegenxBio, Inc. Company Detail
11.34.2 RegenxBio, Inc. Business Overview
11.34.3 RegenxBio, Inc. Viral Vector Production (Research-use) Introduction
11.34.4 RegenxBio, Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024)
11.34.5 RegenxBio, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Viral Vector Production (Research-use) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Adeno-associated virus (AAV)
Table 3. Key Players of Lentivirus
Table 4. Key Players of Adenovirus
Table 5. Key Players of Retrovirus
Table 6. Key Players of Others
Table 7. Global Viral Vector Production (Research-use) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Viral Vector Production (Research-use) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Viral Vector Production (Research-use) Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Viral Vector Production (Research-use) Market Share by Region (2019-2024)
Table 11. Global Viral Vector Production (Research-use) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Viral Vector Production (Research-use) Market Share by Region (2025-2030)
Table 13. Viral Vector Production (Research-use) Market Trends
Table 14. Viral Vector Production (Research-use) Market Drivers
Table 15. Viral Vector Production (Research-use) Market Challenges
Table 16. Viral Vector Production (Research-use) Market Restraints
Table 17. Global Viral Vector Production (Research-use) Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Viral Vector Production (Research-use) Market Share by Players (2019-2024)
Table 19. Global Top Viral Vector Production (Research-use) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Production (Research-use) as of 2023)
Table 20. Ranking of Global Top Viral Vector Production (Research-use) Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Viral Vector Production (Research-use) Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Viral Vector Production (Research-use) Product Solution and Service
Table 24. Date of Enter into Viral Vector Production (Research-use) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viral Vector Production (Research-use) Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Viral Vector Production (Research-use) Revenue Market Share by Type (2019-2024)
Table 28. Global Viral Vector Production (Research-use) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Viral Vector Production (Research-use) Revenue Market Share by Type (2025-2030)
Table 30. Global Viral Vector Production (Research-use) Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Viral Vector Production (Research-use) Revenue Market Share by Application (2019-2024)
Table 32. Global Viral Vector Production (Research-use) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Viral Vector Production (Research-use) Revenue Market Share by Application (2025-2030)
Table 34. North America Viral Vector Production (Research-use) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Viral Vector Production (Research-use) Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Viral Vector Production (Research-use) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Viral Vector Production (Research-use) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Viral Vector Production (Research-use) Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Viral Vector Production (Research-use) Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Viral Vector Production (Research-use) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Viral Vector Production (Research-use) Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Viral Vector Production (Research-use) Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Viral Vector Production (Research-use) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Viral Vector Production (Research-use) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Viral Vector Production (Research-use) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Viral Vector Production (Research-use) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Viral Vector Production (Research-use) Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Viral Vector Production (Research-use) Market Size by Country (2025-2030) & (US$ Million)
Table 49. Merck KGaA Company Detail
Table 50. Merck KGaA Business Overview
Table 51. Merck KGaA Viral Vector Production (Research-use) Product
Table 52. Merck KGaA Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 53. Merck KGaA Recent Development
Table 54. Lonza Company Detail
Table 55. Lonza Business Overview
Table 56. Lonza Viral Vector Production (Research-use) Product
Table 57. Lonza Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 58. Lonza Recent Development
Table 59. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Detail
Table 60. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
Table 61. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product
Table 62. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 63. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
Table 64. Cobra Biologics Ltd. Company Detail
Table 65. Cobra Biologics Ltd. Business Overview
Table 66. Cobra Biologics Ltd. Viral Vector Production (Research-use) Product
Table 67. Cobra Biologics Ltd. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 68. Cobra Biologics Ltd. Recent Development
Table 69. Thermo Fisher Scientific Company Detail
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Viral Vector Production (Research-use) Product
Table 72. Thermo Fisher Scientific Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Waisman Biomanufacturing Company Detail
Table 75. Waisman Biomanufacturing Business Overview
Table 76. Waisman Biomanufacturing Viral Vector Production (Research-use) Product
Table 77. Waisman Biomanufacturing Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 78. Waisman Biomanufacturing Recent Development
Table 79. Genezen Company Detail
Table 80. Genezen Business Overview
Table 81. Genezen Viral Vector Production (Research-use) Product
Table 82. Genezen Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 83. Genezen Recent Development
Table 84. YPOSKESI Company Detail
Table 85. YPOSKESI Business Overview
Table 86. YPOSKESI Viral Vector Production (Research-use) Product
Table 87. YPOSKESI Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 88. YPOSKESI Recent Development
Table 89. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Company Detail
Table 90. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
Table 91. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product
Table 92. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 93. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Development
Table 94. Novasep Holding S.A.S Company Detail
Table 95. Novasep Holding S.A.S Business Overview
Table 96. Novasep Holding S.A.S Viral Vector Production (Research-use) Product
Table 97. Novasep Holding S.A.S Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 98. Novasep Holding S.A.S Recent Development
Table 99. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Company Detail
Table 100. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
Table 101. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product
Table 102. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 103. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Development
Table 104. Vigene Biosciences, Inc. Company Detail
Table 105. Vigene Biosciences, Inc. Business Overview
Table 106. Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product
Table 107. Vigene Biosciences, Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 108. Vigene Biosciences, Inc. Recent Development
Table 109. General Electric Company (GE Healthcare) Company Detail
Table 110. General Electric Company (GE Healthcare) Business Overview
Table 111. General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product
Table 112. General Electric Company (GE Healthcare) Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 113. General Electric Company (GE Healthcare) Recent Development
Table 114. CEVEC Pharmaceuticals GmbH Company Detail
Table 115. CEVEC Pharmaceuticals GmbH Business Overview
Table 116. CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product
Table 117. CEVEC Pharmaceuticals GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 118. CEVEC Pharmaceuticals GmbH Recent Development
Table 119. Batavia Biosciences B.V. Company Detail
Table 120. Batavia Biosciences B.V. Business Overview
Table 121. Batavia Biosciences B.V. Viral Vector Production (Research-use) Product
Table 122. Batavia Biosciences B.V. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 123. Batavia Biosciences B.V. Recent Development
Table 124. Biovion oy Company Detail
Table 125. Biovion oy Business Overview
Table 126. Biovion oy Viral Vector Production (Research-use) Product
Table 127. Biovion oy Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 128. Biovion oy Recent Development
Table 129. Wuxi AppTec Co., Ltd. Company Detail
Table 130. Wuxi AppTec Co., Ltd. Business Overview
Table 131. Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product
Table 132. Wuxi AppTec Co., Ltd. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 133. Wuxi AppTec Co., Ltd. Recent Development
Table 134. VGXI, Inc. Company Detail
Table 135. VGXI, Inc. Business Overview
Table 136. VGXI, Inc. Viral Vector Production (Research-use) Product
Table 137. VGXI, Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 138. VGXI, Inc. Recent Development
Table 139. Catalent Inc. Company Detail
Table 140. Catalent Inc. Business Overview
Table 141. Catalent Inc. Viral Vector Production (Research-use) Product
Table 142. Catalent Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 143. Catalent Inc. Recent Development
Table 144. Miltenyi Biotec GmbH Company Detail
Table 145. Miltenyi Biotec GmbH Business Overview
Table 146. Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product
Table 147. Miltenyi Biotec GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 148. Miltenyi Biotec GmbH Recent Development
Table 149. SIRION Biotech GmbH Company Detail
Table 150. SIRION Biotech GmbH Business Overview
Table 151. SIRION Biotech GmbH Viral Vector Production (Research-use) Product
Table 152. SIRION Biotech GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 153. SIRION Biotech GmbH Recent Development
Table 154. Virovek Incorporation Company Detail
Table 155. Virovek Incorporation Business Overview
Table 156. Virovek Incorporation Viral Vector Production (Research-use) Product
Table 157. Virovek Incorporation Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 158. Virovek Incorporation Recent Development
Table 159. BioNTech IMFS GmbH Company Detail
Table 160. BioNTech IMFS GmbH Business Overview
Table 161. BioNTech IMFS GmbH Viral Vector Production (Research-use) Product
Table 162. BioNTech IMFS GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 163. BioNTech IMFS GmbH Recent Development
Table 164. VIVEbiotech S.L. Company Detail
Table 165. VIVEbiotech S.L. Business Overview
Table 166. VIVEbiotech S.L. Viral Vector Production (Research-use) Product
Table 167. VIVEbiotech S.L. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 168. VIVEbiotech S.L. Recent Development
Table 169. Creative Biogene Company Detail
Table 170. Creative Biogene Business Overview
Table 171. Creative Biogene Viral Vector Production (Research-use) Product
Table 172. Creative Biogene Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 173. Creative Biogene Recent Development
Table 174. Vibalogics GmbH Company Detail
Table 175. Vibalogics GmbH Business Overview
Table 176. Vibalogics GmbH Viral Vector Production (Research-use) Product
Table 177. Vibalogics GmbH Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 178. Vibalogics GmbH Recent Development
Table 179. Takara Bio. Company Detail
Table 180. Takara Bio. Business Overview
Table 181. Takara Bio. Viral Vector Production (Research-use) Product
Table 182. Takara Bio. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 183. Takara Bio. Recent Development
Table 184. Cell and Gene Therapy Catapult Company Detail
Table 185. Cell and Gene Therapy Catapult Business Overview
Table 186. Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product
Table 187. Cell and Gene Therapy Catapult Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 188. Cell and Gene Therapy Catapult Recent Development
Table 189. BlueBird Bio Company Detail
Table 190. BlueBird Bio Business Overview
Table 191. BlueBird Bio Viral Vector Production (Research-use) Product
Table 192. BlueBird Bio Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 193. BlueBird Bio Recent Development
Table 194. Addgene, Inc. Company Detail
Table 195. Addgene, Inc. Business Overview
Table 196. Addgene, Inc. Viral Vector Production (Research-use) Product
Table 197. Addgene, Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 198. Addgene, Inc. Recent Development
Table 199. Aldevron, L.L.C. Company Detail
Table 200. Aldevron, L.L.C. Business Overview
Table 201. Aldevron, L.L.C. Viral Vector Production (Research-use) Product
Table 202. Aldevron, L.L.C. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 203. Aldevron, L.L.C. Recent Development
Table 204. Audentes Therapeutics Company Detail
Table 205. Audentes Therapeutics Business Overview
Table 206. Audentes Therapeutics Viral Vector Production (Research-use) Product
Table 207. Audentes Therapeutics Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 208. Audentes Therapeutics Recent Development
Table 209. BioMarin Pharmaceutical Company Detail
Table 210. BioMarin Pharmaceutical Business Overview
Table 211. BioMarin Pharmaceutical Viral Vector Production (Research-use) Product
Table 212. BioMarin Pharmaceutical Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 213. BioMarin Pharmaceutical Recent Development
Table 214. RegenxBio, Inc. Company Detail
Table 215. RegenxBio, Inc. Business Overview
Table 216. RegenxBio, Inc. Viral Vector Production (Research-use) Product
Table 217. RegenxBio, Inc. Revenue in Viral Vector Production (Research-use) Business (2019-2024) & (US$ Million)
Table 218. RegenxBio, Inc. Recent Development
Table 219. Research Programs/Design for This Report
Table 220. Key Data Information from Secondary Sources
Table 221. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vector Production (Research-use) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Viral Vector Production (Research-use) Market Share by Type: 2023 VS 2030
Figure 3. Adeno-associated virus (AAV) Features
Figure 4. Lentivirus Features
Figure 5. Adenovirus Features
Figure 6. Retrovirus Features
Figure 7. Others Features
Figure 8. Global Viral Vector Production (Research-use) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Viral Vector Production (Research-use) Market Share by Application: 2023 VS 2030
Figure 10. Cell & Gene Therapy Development Case Studies
Figure 11. Vaccine Development Case Studies
Figure 12. Biopharmaceutical and Pharmaceutical Discovery Case Studies
Figure 13. Biomedical Research Case Studies
Figure 14. Viral Vector Production (Research-use) Report Years Considered
Figure 15. Global Viral Vector Production (Research-use) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Viral Vector Production (Research-use) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Viral Vector Production (Research-use) Market Share by Region: 2023 VS 2030
Figure 18. Global Viral Vector Production (Research-use) Market Share by Players in 2023
Figure 19. Global Top Viral Vector Production (Research-use) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Production (Research-use) as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Viral Vector Production (Research-use) Revenue in 2023
Figure 21. North America Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Viral Vector Production (Research-use) Market Share by Country (2019-2030)
Figure 23. United States Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Viral Vector Production (Research-use) Market Share by Country (2019-2030)
Figure 27. Germany Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Viral Vector Production (Research-use) Market Share by Region (2019-2030)
Figure 35. China Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Viral Vector Production (Research-use) Market Share by Country (2019-2030)
Figure 43. Mexico Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Viral Vector Production (Research-use) Market Share by Country (2019-2030)
Figure 47. Turkey Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Viral Vector Production (Research-use) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Merck KGaA Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 50. Lonza Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 51. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 52. Cobra Biologics Ltd. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 54. Waisman Biomanufacturing Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 55. Genezen Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 56. YPOSKESI Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 57. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 58. Novasep Holding S.A.S Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 59. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 60. Vigene Biosciences, Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 61. General Electric Company (GE Healthcare) Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 62. CEVEC Pharmaceuticals GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 63. Batavia Biosciences B.V. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 64. Biovion oy Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 65. Wuxi AppTec Co., Ltd. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 66. VGXI, Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 67. Catalent Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 68. Miltenyi Biotec GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 69. SIRION Biotech GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 70. Virovek Incorporation Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 71. BioNTech IMFS GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 72. VIVEbiotech S.L. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 73. Creative Biogene Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 74. Vibalogics GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 75. Takara Bio. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 76. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 77. BlueBird Bio Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 78. Addgene, Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 79. Aldevron, L.L.C. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 80. Audentes Therapeutics Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 81. BioMarin Pharmaceutical Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 82. RegenxBio, Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2019-2024)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed